Abstract 606: Targeting the immune checkpoint PTPN2 with ABBV-CLS-484 inflames the tumor microenvironment and unleashes potent CD8+ T cell immunity
Arvin Iracheta‐Vellve(Broad Institute), Robert T. Manguso(Broad Institute), Hakimeh Ebrahimi-Nik(Broad Institute), Andrew S. Boghossian(University of California, San Francisco), James C. Patti(Broad Institute), Jennifer M. Frost(Mount Sinai Hospital), Philip R. Kym(AbbVie (United States)), Clay Beauregard, Cun Lan Chuong(Broad Institute), Mitchell D. Yeary(Broad Institute), Jennifer A. Roth(Broad Institute), Ian C. Kohnle(Broad Institute), Elliot P. Farney(AbbVie (United States)), Kathleen A. McGuire(AbbVie (United States)), Keith M. Hamel(AbbVie (United States)), Matthew G. Rees(Broad Institute), Kathleen B. Yates(Broad Institute), Gabriel K. Griffin(Harvard University), Kira E. Olander(Broad Institute), Zhaoming Xiong(AbbVie (United States)), Sarah Kim(University of Miami), Christina K. Baumgartner(AbbVie (United States)), Todd R. Golub(Broad Institute), Thomas R. A. Davis(Broad Institute), Melissa M. Ronan(Broad Institute)
Cited by 8
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Molecular Classification of Cancer: Class Discovery and Class Prediction by Gene Expression Monitoring
|Science|1999|11.6k
PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes
|Nature Genetics|2003|10.6k
The Connectivity Map: Using Gene-Expression Signatures to Connect Small Molecules, Genes, and Disease
|Science|2006|5.5k
Copper induces cell death by targeting lipoylated TCA cycle proteins
|Science|2022|4.6k